Literature DB >> 25904048

The neuropathology of chronic traumatic encephalopathy.

Ann C McKee1, Thor D Stein, Patrick T Kiernan, Victor E Alvarez.   

Abstract

Repetitive brain trauma is associated with a progressive neurological deterioration, now termed as chronic traumatic encephalopathy (CTE). Most instances of CTE occur in association with the play of sports, but CTE has also been reported in association with blast injuries and other neurotrauma. Symptoms of CTE include behavioral and mood changes, memory loss, cognitive impairment and dementia. Like many other neurodegenerative diseases, CTE is diagnosed with certainty only by neuropathological examination of brain tissue. CTE is a tauopathy characterized by the deposition of hyperphosphorylated tau (p-tau) protein as neurofibrillary tangles, astrocytic tangles and neurites in striking clusters around small blood vessels of the cortex, typically at the sulcal depths. Severely affected cases show p-tau pathology throughout the brain. Abnormalities in phosphorylated 43 kDa TAR DNA-binding protein are found in most cases of CTE; beta-amyloid is identified in 43%, associated with age. Given the importance of sports participation and physical exercise to physical and psychological health as well as disease resilience, it is critical to identify the genetic risk factors for CTE as well as to understand how other variables, such as stress, age at exposure, gender, substance abuse and other exposures, contribute to the development of CTE.
© 2015 International Society of Neuropathology.

Entities:  

Keywords:  Alzheimer's disease; TDP-43; chronic traumatic encephalopathy; tauopathy; traumatic brain injury

Mesh:

Substances:

Year:  2015        PMID: 25904048      PMCID: PMC4526170          DOI: 10.1111/bpa.12248

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  99 in total

1.  Protecting the boxer.

Authors:  I A McCOWN
Journal:  J Am Med Assoc       Date:  1959-03-28

2.  CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease.

Authors:  Katharina Buerger; Michael Ewers; Tuula Pirttilä; Raymond Zinkowski; Irina Alafuzoff; Stefan J Teipel; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Hilkka Soininen; Harald Hampel
Journal:  Brain       Date:  2006-09-29       Impact factor: 13.501

3.  Chronic traumatic encephalopathy in a professional American wrestler.

Authors:  Bennet I Omalu; Robert P Fitzsimmons; Jennifer Hammers; Julian Bailes
Journal:  J Forensic Nurs       Date:  2010       Impact factor: 1.175

4.  Compression alters kinase and phosphatase activity and tau and MAP2 phosphorylation transiently while inducing the fast adaptive dendritic remodeling of underlying cortical neurons.

Authors:  Li-Jin Chen; Yueh-Jan Wang; Guo-Fang Tseng
Journal:  J Neurotrauma       Date:  2010-09       Impact factor: 5.269

5.  Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease.

Authors:  M L Schmidt; V Zhukareva; K L Newell; V M Lee; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  2001-05       Impact factor: 17.088

6.  Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury.

Authors:  Katie Moisse; Kathryn Volkening; Cheryl Leystra-Lantz; Ian Welch; Tracy Hill; Michael J Strong
Journal:  Brain Res       Date:  2008-11-01       Impact factor: 3.252

Review 7.  Cross currents in protein misfolding disorders: interactions and therapy.

Authors:  Rodrigo Morales; Kristi M Green; Claudio Soto
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-11       Impact factor: 4.388

8.  The spectrum of disease in chronic traumatic encephalopathy.

Authors:  Ann C McKee; Robert A Stern; Christopher J Nowinski; Thor D Stein; Victor E Alvarez; Daniel H Daneshvar; Hyo-Soon Lee; Sydney M Wojtowicz; Garth Hall; Christine M Baugh; David O Riley; Caroline A Kubilus; Kerry A Cormier; Matthew A Jacobs; Brett R Martin; Carmela R Abraham; Tsuneya Ikezu; Robert Ross Reichard; Benjamin L Wolozin; Andrew E Budson; Lee E Goldstein; Neil W Kowall; Robert C Cantu
Journal:  Brain       Date:  2012-12-02       Impact factor: 13.501

9.  Neurodegenerative and other chronic disorders among people aged 75 years and over in the community.

Authors:  L M Waite; G A Broe; H Creasey; D A Grayson; J S Cullen; B O'Toole; D Edelbrock; M Dobson
Journal:  Med J Aust       Date:  1997-10-20       Impact factor: 7.738

Review 10.  TDP-43 in central nervous system development and function: clues to TDP-43-associated neurodegeneration.

Authors:  Chantelle F Sephton; Basar Cenik; Bercin Kutluk Cenik; Joachim Herz; Gang Yu
Journal:  Biol Chem       Date:  2012-07       Impact factor: 3.915

View more
  145 in total

1.  Primary chronic traumatic encephalopathy in an older patient with late-onset AD phenotype.

Authors:  Carolyn A Fredericks; Mary Koestler; William Seeley; Bruce Miller; Adam Boxer; Lea T Grinberg
Journal:  Neurol Clin Pract       Date:  2015-12

2.  Predicting Risk of Sport-Related Concussion in Collegiate Athletes and Military Cadets: A Machine Learning Approach Using Baseline Data from the CARE Consortium Study.

Authors:  Joel Castellanos; Cheng Perng Phoo; James T Eckner; Lea Franco; Steven P Broglio; Mike McCrea; Thomas McAllister; Jenna Wiens
Journal:  Sports Med       Date:  2021-03       Impact factor: 11.136

3.  Repeated Mild Head Injury Leads to Wide-Ranging Deficits in Higher-Order Cognitive Functions Associated with the Prefrontal Cortex.

Authors:  Amber Nolan; Edel Hennessy; Karen Krukowski; Caroline Guglielmetti; Myriam M Chaumeil; Vikaas S Sohal; Susanna Rosi
Journal:  J Neurotrauma       Date:  2018-07-02       Impact factor: 5.269

Review 4.  The neuropathology of chronic traumatic encephalopathy.

Authors:  Ann C McKee; Thor D Stein; Patrick T Kiernan; Victor E Alvarez
Journal:  Brain Pathol       Date:  2015-05       Impact factor: 6.508

Review 5.  Repetitive Head Impacts and Chronic Traumatic Encephalopathy.

Authors:  Ann C McKee; Michael L Alosco; Bertrand R Huber
Journal:  Neurosurg Clin N Am       Date:  2016-10       Impact factor: 2.509

6.  The influence of tau, amyloid, alpha-synuclein, TDP-43, and vascular pathology in clinically normal elderly individuals.

Authors:  Alexandra M Wennberg; Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Melissa E Murray; Mary M Machulda; Leonard Petrucelli; Michelle M Mielke; Clifford R Jack; David S Knopman; Joseph E Parisi; Ronald C Petersen; Dennis W Dickson; Keith A Josephs
Journal:  Neurobiol Aging       Date:  2019-01-21       Impact factor: 4.673

7.  A Mechanical Brain Damage Framework Used to Model Abnormal Brain Tau Protein Accumulations of National Football League Players.

Authors:  M F Horstemeyer; P R Berthelson; J Moore; A K Persons; A Dobbins; R K Prabhu
Journal:  Ann Biomed Eng       Date:  2019-08-01       Impact factor: 3.934

Review 8.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

Review 9.  Experimental Designs for Repeated Mild Traumatic Brain Injury: Challenges and Considerations.

Authors:  Amanda N Bolton-Hall; W Brad Hubbard; Kathryn E Saatman
Journal:  J Neurotrauma       Date:  2018-11-22       Impact factor: 5.269

Review 10.  Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy.

Authors:  Gabor G Kovacs; Isidro Ferrer; Lea T Grinberg; Irina Alafuzoff; Johannes Attems; Herbert Budka; Nigel J Cairns; John F Crary; Charles Duyckaerts; Bernardino Ghetti; Glenda M Halliday; James W Ironside; Seth Love; Ian R Mackenzie; David G Munoz; Melissa E Murray; Peter T Nelson; Hitoshi Takahashi; John Q Trojanowski; Olaf Ansorge; Thomas Arzberger; Atik Baborie; Thomas G Beach; Kevin F Bieniek; Eileen H Bigio; Istvan Bodi; Brittany N Dugger; Mel Feany; Ellen Gelpi; Stephen M Gentleman; Giorgio Giaccone; Kimmo J Hatanpaa; Richard Heale; Patrick R Hof; Monika Hofer; Tibor Hortobágyi; Kurt Jellinger; Gregory A Jicha; Paul Ince; Julia Kofler; Enikö Kövari; Jillian J Kril; David M Mann; Radoslav Matej; Ann C McKee; Catriona McLean; Ivan Milenkovic; Thomas J Montine; Shigeo Murayama; Edward B Lee; Jasmin Rahimi; Roberta D Rodriguez; Annemieke Rozemüller; Julie A Schneider; Christian Schultz; William Seeley; Danielle Seilhean; Colin Smith; Fabrizio Tagliavini; Masaki Takao; Dietmar Rudolf Thal; Jon B Toledo; Markus Tolnay; Juan C Troncoso; Harry V Vinters; Serge Weis; Stephen B Wharton; Charles L White; Thomas Wisniewski; John M Woulfe; Masahito Yamada; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2015-12-10       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.